叶酸充足女性孕前叶酸状态与生殖结局的前瞻性队列研究
本研究嵌套于阿司匹林对妊娠与生殖影响试验,纳入1228名有1-2次妊娠丢失史、无不孕记录的美国女性,每日补充叶酸400 μg。分析孕前血清叶酸和血浆同型半胱氨酸与排卵障碍、妊娠及妊娠丢失的关联。仅在2次妊娠丢失史女性中,血浆同型半胱氨酸升高与妊娠丢失风险增加非线性相关。
要点
- 孕前血浆同型半胱氨酸升高仅在有2次妊娠丢失史女性中与妊娠丢失风险增加相关。
- 血清叶酸与任何生殖结局均无有意义关联。
- 血浆同型半胱氨酸与排卵障碍或妊娠均无有意义关联。
核心结论
- 这些数据为进一步研究叶酸和同型半胱氨酸代谢在正常和异常早期妊娠中的作用提供了依据。
研究设计与样本
- 嵌套于阿司匹林对妊娠与生殖影响试验的队列研究,该试验为区组随机、双盲、安慰剂对照试验,女性随机接受每日低剂量阿司匹林(81 mg/天)或安慰剂,所有女性均接受叶酸(400 μg/天)。
- 共纳入1228名有1-2次既往妊娠丢失且无记录不孕的女性,来自美国4个临床中心(2006-2012年),尝试妊娠至多6个月经周期。
主要发现
- 仅在2次既往妊娠丢失女性中,血浆同型半胱氨酸升高与妊娠丢失风险增加非线性相关:血浆同型半胱氨酸浓度在研究的中位数8.0 μmol/L对比美国人群的中位数6.0 μmol/L时,相对风险为1.43(95%置信区间1.08-1.89)。
- 血清叶酸与任何生殖结局之间均未发现有意义的关系。
- 血浆同型半胱氨酸与排卵障碍或受孕之间均未发现有意义的关系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most studies of folate metabolism and reproduction have been conducted after pregnancy and in folate-deficient populations. However, measurement of maternal folate status preconceptionally may be most relevant to certain folate-linked early processes preceding a successful pregnancy, and there has been a major increase in folate concentrations in women of childbearing age in high resource settings. OBJECTIVE: To examine associations between preconceptional biomarkers of maternal folate status (folate and homocysteine) and reproductive outcomes in folate-replete women. STUDY DESIGN: Cohort nested within the Effects of Aspirin in Gestation and Reproduction trial, a block-randomized, double-blind, placebo-controlled trial whereby women were randomized to daily low-dose aspirin (81 mg/day) or placebo and all women received folic acid (400 μg/day). In total, 1228 women with 1-2 previous pregnancy losses and no documented infertility were recruited from 4 clinical sites in the United States (2006-2012) and were attempting pregnancy for up to 6 menstrual cycles. Log-binomial regression models were used to estimate relative risks and 95% confidence intervals between preconception serum folate and plasma homocysteine for anovulation, pregnancy, and pregnancy loss. RESULTS: Greater plasma homocysteine was nonlinearly associated with greater risks of pregnancy loss only among women with 2 previous losses: a relative risk of 1.43 (95% confidence interval, 1.08-1.89) was found for plasma homocysteine concentrations at the study median of 8.0 μmol/L compared with a US population median of 6.0 μmol/L. No meaningful relationships were found between serum folate and any reproductive outcome or between plasma homocysteine and anovulation or becoming pregnant. CONCLUSION: These data justify further study of the role of folate and homocysteine metabolism in normal and abnormal early pregnancy.
引用
- DeVilbiss EA, Mumford SL, Sjaarda LA, et al. Preconception folate status and reproductive outcomes among a prospective cohort of folate-replete women. Am J Obstet Gynecol. 2019. PMID: 30807767. doi:10.1016/j.ajog.2019.02.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。